Today's Issue: Eli Lilly responds to Allie’s C-peptide inquiry
A simple voicemail provides a simple answer to Allie's crusade chasing C-peptide. Eli Lilly claims to make human insulin but they advise Allie to look for proprietary consumer companies to buy C-peptide. What kind of a suggestion is that? No más Lilly! C-peptide is a God-given piece of natural insulin production. There is no need for proprietary measures if you are truly making human insulin. When one door closes another one opens. The crusade continues.
- Please SUBSCRIBE to support "Allies Voice" - it's FREE!
- Sigma Aldrich C-peptide description
- Dictionary.com definition of proprietary - see example 5!
- Join me on TuDiabetes.com!
Just as I suspected ... I told you, but you had to go and prove it, didn't you? LOL, its curious that they recommended you find a company that distributes C-Peptide, considering there aren't any (even in Israel). Perhaps you'd have better luck in Eastern Europe. A Polish company is already selling a Humalog clone for half the price, although as an analyst once warned "I'd be careful of getting a biopharmaceutical made in someone's garage in Poland or Lithuania!"
Reply to this
Allie........
Because of the success that was followed at the Royal Institute of Technology in Stockholm Sweden with the administration of C-peptide via exogenous route to those with Type 1 Diabetes in the area of vascular blood flow, kidney function, autonomic nerve function, improved retina vascularity, and sensory function; the beginnings of the company called, Creative Peptides was formed.
No company is going to invest a huge amount of resources and money into a product that does not perform well and is "risky." Although in R&D this sometimes happens, especially in Pharmaceuticals.
Since the risk of Diabetes-Related Complications are very much a part of this Disease(T1DM), whether or not the person has "good numbers." Thus the availability and administration of C-peptide becomes as important as is the administration of exogenous Insulin.
From Creative Peptides:
"C-peptide replacement in Type 1 diabetes
Improves sensory nerve dysfunction and structural abnormalities (increased SNCV, vibration perception, regression of nodal changes, increased axonal regeneration) and improves autonomic nerve function (heart rate variability)
Improves renal dysfunction (normalized glomerular filtration, decreased albumin excretion) and reduces diabetes-induced structural changes (decreases mesangial expansion)
Increases regional blood flow (muscle, myocardium, nerve and kidney)."
Not to have this product made available to those of us with long-standing T1DM, regardless of Complications would be medically unethical and criminal in scope.
Creative Peptides are now in Phase ll of their clinical research using C-peptide in test subjects.
Reply to this
Hello Allie,
Well I think this very typical of what Eli Lilly is really all about and based on the recent articles of people who have worked there it is very clear to me and you and hopefully others that these guys only care about the money. You know what else I have not heard about in a very long time was anyone really working on the so called cure. You don't hear much about that any more like you use to. Again, I believe it is the money that keeps us sick and weak and at their mercy. Talk about a cure Stem Cells, or anything but no one talks about working on a cure. Other then the people who you are in contact with. Keep up the good work and give them hell. Because these crooks deserve it. Thank you Allie.
Reply to this
Allie,
In case you missed it you should check out this story on c-peptide. love your site! -Fred
http://www.diabeteshealth.com/read/2008/01/03/5612.html
Reply to this